Osiris Therapeutics, Inc. (Nasdaq: OSIR) to Ring The Nasdaq Stock Market Opening Bell
August 05 2016 - 10:00AM
What: Osiris Therapeutics,
Inc. (Nasdaq:OSIR), the leading cellular regenerative medicine
company focused on developing and marketing products to treat
conditions in wound care, orthopaedics and sports medicine, will
visit the Nasdaq MarketSite in Times Square in celebration of the
company’s 10 year listing anniversary.
In honor of the occasion, Peter Friedli,
Co-founder and Chairman will ring the Opening
Bell.
Where:Nasdaq MarketSite – 4 Times
Square – 43rd & Broadway – Broadcast Studio
When:Monday, August 8, 2016 – 9:15
a.m. to 9:30 a.m. ET
Osiris Therapeutics Media
Contact:Diane
Savoie443-545-1834 Osirispr@osiris.com
Nasdaq MarketSite:Emily Pan(646)
441-5120 emily.pan@nasdaq.com
Feed Information:Fiber Line
(Encompass Waterfront): 4463
Gal 3C/06C 95.05 degrees West 18 mhz Lower DL 3811
Vertical FEC 3/4 SR 13.235 DR 18.295411 MOD 4:2:0 DVBS QPSK
Social Media:For multimedia
features such as exclusive content, photo postings, status updates
and video of bell ceremonies, please visit our Facebook
page:http://www.facebook.com/NASDAQ.
For photos from ceremonies and events, please visit
our Instagram page:http://instagram.com/nasdaq
For livestream of ceremonies and events, please
visit our YouTube page:http://www.youtube.com/nasdaq/live
For news tweets, please visit our Twitter
page:http://twitter.com/nasdaq
For exciting viral content and ceremony photos,
please visit our Tumblr page:http://nasdaq.tumblr.com/
Webcast: A live stream of the
Nasdaq Opening Bell will be available at:
https://new.livestream.com/nasdaq/live or
http://www.nasdaq.com/about/marketsitetowervideo.asx
Photos: To obtain a hi-resolution
photograph of the Market Open, please go to
http://business.nasdaq.com/discover/market-bell-ceremonies and
click on the market open of your choice.
About Osiris
TherapeuticsHeadquartered in Columbia, Maryland, Osiris
Therapeutics is a leader in researching, developing and marketing
cellular regenerative medicine products that improve the health and
lives of patients and lower overall healthcare costs. Having
developed the world's first approved stem cell drug, Osiris works
to further advance the medical field. Osiris' research and
development in biotechnology focuses on innovation in regenerative
medicine - including stem cell research, bioengineering and viable
tissue based products. Osiris has achieved commercial success with
products in orthopaedics, sports medicine and wound care, including
BIO4®, a viable bone matrix, Cartiform®, a viable osteochondral
allograft, Grafix®, a cryopreserved placental membrane, TruSkin™, a
viable human skin allograft and Stravix™, a durable placental
allograft.
Osiris, Grafix and Cartiform are registered
trademarks of Osiris Therapeutics, Inc.; TruSkin and Stravix are
trademarks of Osiris Therapeutics, Inc. BIO4 is a registered
trademark of Howmedica Osteonics Corporation. More information can
be found on the company's website, www.Osiris.com.
About NasdaqNasdaq (Nasdaq:NDAQ)
is a leading provider of trading, clearing, exchange technology,
listing, information and public company services across six
continents. Through its diverse portfolio of solutions, Nasdaq
enables customers to plan, optimize and execute their business
vision with confidence, using proven technologies that provide
transparency and insight for navigating today's global capital
markets. As the creator of the world's first electronic stock
market, its technology powers more than 70 marketplaces in 50
countries, and 1 in 10 of the world's securities transactions.
Nasdaq is home to more than 3,700 listed companies with a market
value of approximately $9.3 trillion and nearly 18,000 corporate
clients. To learn more, visit: nasdaq.com/ambition or
business.nasdaq.com.
-NDAQA-
Osiris Therapeutics, Inc. (NASDAQ:OSIR)
Historical Stock Chart
From Aug 2024 to Sep 2024
Osiris Therapeutics, Inc. (NASDAQ:OSIR)
Historical Stock Chart
From Sep 2023 to Sep 2024